Logo image of TNX.MI

TENAX INTERNATIONAL SPA (TNX.MI) Stock Fundamental Analysis

BIT:TNX - IT0005428898 - Common Stock

2.08 EUR
-0.14 (-6.31%)
Last: 8/18/2025, 7:00:00 PM
Fundamental Rating

3

Overall TNX gets a fundamental rating of 3 out of 10. We evaluated TNX against 0 industry peers in the Unkown industry. TNX has a bad profitability rating. Also its financial health evaluation is rather negative. TNX is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

TNX had positive earnings in the past year.
TNX had a negative operating cash flow in the past year.
In the past 5 years TNX has always been profitable.
In multiple years TNX reported negative operating cash flow during the last 5 years.
TNX.MI Yearly Net Income VS EBIT VS OCF VS FCFTNX.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 1M -1M 2M -2M -3M

1.2 Ratios

The 3 year average ROIC (4.37%) for TNX is below the current ROIC(7.35%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.56%
ROE 8.58%
ROIC 7.35%
ROA(3y)1.75%
ROA(5y)1.57%
ROE(3y)5.36%
ROE(5y)4.78%
ROIC(3y)4.37%
ROIC(5y)3.53%
TNX.MI Yearly ROA, ROE, ROICTNX.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

In the last couple of years the Profit Margin of TNX has declined.
In the last couple of years the Operating Margin of TNX has declined.
In the last couple of years the Gross Margin of TNX has declined.
Industry RankSector Rank
OM 5.01%
PM (TTM) 1.85%
GM 29.72%
OM growth 3Y-4.27%
OM growth 5Y-9.86%
PM growth 3Y-43.1%
PM growth 5Y-21.55%
GM growth 3Y0.44%
GM growth 5Y-6.23%
TNX.MI Yearly Profit, Operating, Gross MarginsTNX.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), TNX is creating some value.
Compared to 1 year ago, TNX has more shares outstanding
Compared to 5 years ago, TNX has more shares outstanding
TNX has a worse debt/assets ratio than last year.
TNX.MI Yearly Shares OutstandingTNX.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
TNX.MI Yearly Total Debt VS Total AssetsTNX.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

An Altman-Z score of 2.27 indicates that TNX is not a great score, but indicates only limited risk for bankruptcy at the moment.
A Debt/Equity ratio of 0.50 indicates that TNX is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF N/A
Altman-Z 2.27
ROIC/WACC1.3
WACC5.64%
TNX.MI Yearly LT Debt VS Equity VS FCFTNX.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M

2.3 Liquidity

TNX has a Current Ratio of 1.47. This is a normal value and indicates that TNX is financially healthy and should not expect problems in meeting its short term obligations.
TNX has a Quick Ratio of 1.47. This is a bad value and indicates that TNX is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.47
Quick Ratio 0.66
TNX.MI Yearly Current Assets VS Current LiabilitesTNX.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

5

3. Growth

3.1 Past

TNX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -14.98%.
Measured over the past years, TNX shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.90% on average per year.
The Revenue has grown by 67.68% in the past year. This is a very strong growth!
Measured over the past years, TNX shows a very strong growth in Revenue. The Revenue has been growing by 20.95% on average per year.
EPS 1Y (TTM)-14.98%
EPS 3Y-28.96%
EPS 5Y-8.9%
EPS Q2Q%-82.56%
Revenue 1Y (TTM)67.68%
Revenue growth 3Y27.82%
Revenue growth 5Y20.95%
Sales Q2Q%90.32%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
Based on estimates for the next years, TNX will show a quite strong growth in Revenue. The Revenue will grow by 10.81% on average per year.
EPS Next Y13.04%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year20%
Revenue Next 2Y19.46%
Revenue Next 3Y10.81%
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
TNX.MI Yearly Revenue VS EstimatesTNX.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M
TNX.MI Yearly EPS VS EstimatesTNX.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 0 0.05 0.1 0.15 0.2 0.25

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 12.24 indicates a correct valuation of TNX.
The average S&P500 Price/Earnings ratio is at 27.08. TNX is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 7.92 indicates a rather cheap valuation of TNX.
TNX is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.72, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.24
Fwd PE 7.92
TNX.MI Price Earnings VS Forward Price EarningsTNX.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.95
TNX.MI Per share dataTNX.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

TNX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.94
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for TNX!.
Industry RankSector Rank
Dividend Yield N/A

TENAX INTERNATIONAL SPA

BIT:TNX (8/18/2025, 7:00:00 PM)

2.08

-0.14 (-6.31%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners8.98%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap7.65M
Analysts80
Price Target4.59 (120.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 12.24
Fwd PE 7.92
P/S 0.22
P/FCF N/A
P/OCF N/A
P/B 1.03
P/tB 2.34
EV/EBITDA 5.95
EPS(TTM)0.17
EY8.17%
EPS(NY)0.26
Fwd EY12.63%
FCF(TTM)-0.65
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS9.32
BVpS2.01
TBVpS0.89
PEG (NY)0.94
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.56%
ROE 8.58%
ROCE 14.56%
ROIC 7.35%
ROICexc 8.95%
ROICexgc 15.57%
OM 5.01%
PM (TTM) 1.85%
GM 29.72%
FCFM N/A
ROA(3y)1.75%
ROA(5y)1.57%
ROE(3y)5.36%
ROE(5y)4.78%
ROIC(3y)4.37%
ROIC(5y)3.53%
ROICexc(3y)5.47%
ROICexc(5y)4.51%
ROICexgc(3y)8.92%
ROICexgc(5y)7.25%
ROCE(3y)8.66%
ROCE(5y)6.99%
ROICexcg growth 3Y29.72%
ROICexcg growth 5Y-0.43%
ROICexc growth 3Y20.18%
ROICexc growth 5Y-4.32%
OM growth 3Y-4.27%
OM growth 5Y-9.86%
PM growth 3Y-43.1%
PM growth 5Y-21.55%
GM growth 3Y0.44%
GM growth 5Y-6.23%
F-Score4
Asset Turnover1.38
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF N/A
Debt/EBITDA 1.37
Cap/Depr 221.79%
Cap/Sales 6.21%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.47
Quick Ratio 0.66
Altman-Z 2.27
F-Score4
WACC5.64%
ROIC/WACC1.3
Cap/Depr(3y)186.07%
Cap/Depr(5y)182.89%
Cap/Sales(3y)8.35%
Cap/Sales(5y)9.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.98%
EPS 3Y-28.96%
EPS 5Y-8.9%
EPS Q2Q%-82.56%
EPS Next Y13.04%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)67.68%
Revenue growth 3Y27.82%
Revenue growth 5Y20.95%
Sales Q2Q%90.32%
Revenue Next Year20%
Revenue Next 2Y19.46%
Revenue Next 3Y10.81%
Revenue Next 5YN/A
EBIT growth 1Y29.41%
EBIT growth 3Y22.36%
EBIT growth 5Y9.03%
EBIT Next Year128.57%
EBIT Next 3Y45.26%
EBIT Next 5YN/A
FCF growth 1Y-53.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2101.57%
OCF growth 3YN/A
OCF growth 5YN/A